The intramyocardial injection of anti-TXNIP siRNA also decreases the size of the infarction and the activation of NLRP3, which suggests the value of targeting TXNIP to prevent deleterious effects of ischemia [209]. This evidence concerns the gene TXNIP and ischemia.